investorscraft@gmail.com

Intrinsic ValueGoHealth, Inc. (GOCO)

Previous Close$2.16
Intrinsic Value
Upside potential
Previous Close
$2.16

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

GoHealth, Inc. operates as a health insurance marketplace and technology platform, primarily serving Medicare-eligible individuals. The company leverages data-driven algorithms and proprietary technology to match consumers with suitable insurance plans, generating revenue through commissions from insurers. GoHealth differentiates itself through its multi-carrier platform, which offers a broad range of Medicare Advantage, Medicare Supplement, and other health insurance products. The company operates in a highly competitive and regulated sector, where its ability to scale efficiently and maintain strong insurer relationships is critical. GoHealth’s market position is bolstered by its digital-first approach, which streamlines the enrollment process and enhances consumer experience. However, the company faces challenges from regulatory changes, shifting insurer compensation models, and competition from both traditional brokers and emerging insurtech players. Its long-term success hinges on sustaining enrollment growth while optimizing marketing spend and operational efficiency.

Revenue Profitability And Efficiency

GoHealth reported revenue of $798.9 million for FY 2024, reflecting its scale in the health insurance brokerage market. The company posted a net loss of $2.9 million, with diluted EPS of -$0.29, indicating ongoing profitability challenges. Operating cash flow was negative at $21.6 million, while capital expenditures totaled $13.7 million, suggesting continued investment in technology and infrastructure despite financial pressures.

Earnings Power And Capital Efficiency

The company’s negative earnings and operating cash flow highlight inefficiencies in converting revenue to profitability. High customer acquisition costs and reliance on insurer commissions may constrain earnings power. Capital efficiency remains a concern, as GoHealth balances growth investments with the need to achieve sustainable cash flow generation in a competitive and cyclical industry.

Balance Sheet And Financial Health

GoHealth’s balance sheet shows $40.9 million in cash and equivalents against $528 million in total debt, indicating significant leverage. The high debt load raises liquidity concerns, particularly given the company’s negative operating cash flow. Financial health depends on improving profitability and managing debt obligations amid uncertain enrollment and commission trends.

Growth Trends And Dividend Policy

GoHealth’s growth is tied to Medicare enrollment trends and its ability to expand its technology-driven brokerage platform. The company does not pay dividends, reinvesting available cash into operations and growth initiatives. Future performance will depend on scaling its platform efficiently and adapting to regulatory and competitive dynamics in the health insurance market.

Valuation And Market Expectations

Market expectations for GoHealth appear muted, given its profitability challenges and leveraged balance sheet. Investors likely focus on the company’s ability to stabilize earnings and reduce debt. Valuation metrics may reflect skepticism about near-term turnaround prospects, with attention on operational execution and potential strategic shifts.

Strategic Advantages And Outlook

GoHealth’s proprietary technology and established insurer relationships provide a foundation for recovery, but execution risks remain high. The outlook depends on improving unit economics, reducing debt, and navigating regulatory headwinds. Success in these areas could position the company for sustainable growth, though near-term uncertainty persists.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount